1. Home
  2. QNTM vs JFB Comparison

QNTM vs JFB Comparison

Compare QNTM & JFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • JFB
  • Stock Information
  • Founded
  • QNTM 1998
  • JFB 2014
  • Country
  • QNTM Canada
  • JFB United States
  • Employees
  • QNTM N/A
  • JFB N/A
  • Industry
  • QNTM
  • JFB
  • Sector
  • QNTM
  • JFB
  • Exchange
  • QNTM NYSE
  • JFB NYSE
  • Market Cap
  • QNTM 69.3M
  • JFB 68.6M
  • IPO Year
  • QNTM N/A
  • JFB 2025
  • Fundamental
  • Price
  • QNTM $25.15
  • JFB $7.69
  • Analyst Decision
  • QNTM
  • JFB
  • Analyst Count
  • QNTM 0
  • JFB 0
  • Target Price
  • QNTM N/A
  • JFB N/A
  • AVG Volume (30 Days)
  • QNTM 188.7K
  • JFB 43.2K
  • Earning Date
  • QNTM 08-13-2025
  • JFB 08-11-2025
  • Dividend Yield
  • QNTM N/A
  • JFB N/A
  • EPS Growth
  • QNTM N/A
  • JFB N/A
  • EPS
  • QNTM N/A
  • JFB 0.00
  • Revenue
  • QNTM N/A
  • JFB $25,946,544.00
  • Revenue This Year
  • QNTM N/A
  • JFB N/A
  • Revenue Next Year
  • QNTM N/A
  • JFB N/A
  • P/E Ratio
  • QNTM N/A
  • JFB $1,980.47
  • Revenue Growth
  • QNTM N/A
  • JFB N/A
  • 52 Week Low
  • QNTM $2.70
  • JFB $3.39
  • 52 Week High
  • QNTM $38.25
  • JFB $10.46
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 61.07
  • JFB N/A
  • Support Level
  • QNTM $21.63
  • JFB N/A
  • Resistance Level
  • QNTM $24.61
  • JFB N/A
  • Average True Range (ATR)
  • QNTM 2.37
  • JFB 0.00
  • MACD
  • QNTM 0.27
  • JFB 0.00
  • Stochastic Oscillator
  • QNTM 91.60
  • JFB 0.00

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

About JFB JFB CONSTRUCTION HOLDINGS

JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.

Share on Social Networks: